BioSpace News Archive

Soin Neuroscience, a biotechnology company based in Dayton, OH, has developed a new spinal cord stimulation device to treat chronic pain.

Moberg Pharma AB has now completed the expert evaluation of the results from the North American Phase 3-study.

PharmaMar and Jazz signed an exclusive license agreement on 19 December 2019 for lurbinectedin in the United States

International medical imaging IT and cybersecurity company Sectra has signed a digital pathology contract with the Dutch hospital Zuyderland MC.

Technavio has announced its latest market research report titled global blister packaging machinery market 2020-2024.

Kurin Inc., the inventor and manufacturer of 510-cleared and patented Kurin® blood culture collection sets, announced the hiring of Don Canal to the newly created position of Executive Vice President, Operations.

CytoSorbents Corporation (NASDAQ:CTSO), a critical care immunotherapy leader specializing in blood purification, highlights the recent publication entitled, “Hemoadsorption Improves Survival of Rats Exposed to an Acutely Lethal Dose of Aflatoxin B1" in the journal, Scientific Reports, a Nature Research publication.

Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2019. “We delivered strong underlying sales and earnings growth in 2019, driven by the strength of our Pharmaceutical business, accelerating performance in our Medical Devices business and improved profitability in our Consumer business,” said Alex Gorsky, Chairman and Chief Executive Officer

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today stated that the previously announced abstract for a poster to be presented at the 2020 Gastrointestinal Cancers Symposium sponsored by ASCO in San Francisco, has been published

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) is pleased to announce that Judy Schmeling has been appointed Chair of the Board of Directors and Jim Sabia has been appointed in principle as a member of the Company’s Board of Directors.